Abstract Serologic diagnosis has been presented as a safe alternative for coccidioidomycosis. However, commercial kits based on coccidioidal antibodies available in the USA are considered too expensive for laboratories outside that country. In this study, we describe the preparation of antigens for detection of human coccidioidal antibodies by the immunodiffusion test (ID) and enzyme immunoassay (EIA).
Introduction
Coccidioidomycosis (CM) is a deep infection caused by Coccidioides immitis and C. posadasii, found exclusively in the Americas [1] . Both species are soilinhabitant dimorphic fungi and infect humans and animals after inhalation of their asexual arthroconidia [2] . Approximately 60 % of infected individuals are asymptomatic and develop a protective cell-mediated response [3] . The remaining 40 % can show any of the following clinical manifestations: acute pneumonia, chronic progressive pneumonia, pulmonary nodules and cavities and disseminated disease [3, 4] . Since clinical findings are unspecific, CM can mimic several other community-acquired pneumonias [5, 6] , tuberculosis [7] and malignancy [8] . Therefore, the importance of correct diagnosis is unquestionable.
Many approaches are currently available for laboratory diagnosis of CM: recovery of Coccidioides spp. by culture [9, 10] ; detection of fungal spherules on clinical specimens by microscopy [11, 12] ; histopathology [11, 12] ; molecular-based techniques directly with clinical specimens [13, 14] or cultures [15, 16] ; serology [10, 12] ; and skin testing [17] . Although a positive culture of Coccidioides spp. remains the ''gold standard'' for a conclusive diagnosis [9] , clinical laboratories must have BL3 facilities for secure handling of fungal cultures, which is an important hindrance to many institutions [18] . Therefore, strategies for improvement of CM diagnosis should be encouraged [10, 18, 19] .
Diagnosis based on serology has been considered a useful alternative in CM [20] . Although antibodies (Ab) have virtually no effect on protection against the disease, Ab titers are considered a good predictor of the infection status [11] . Several approaches have been used to measure the serologic response for diagnosis and follow-up of patients with CM: complement fixation, immunodiffusion (ID), latex agglutination and enzyme immunoassay (EIA). In Brazil, serological diagnosis of CM is mainly performed by ID and EIA techniques [18, 21, 22] . Although both ID and EIA commercial kits are currently available for detection of coccidioidal antibodies, they are too expensive for many laboratories outside the USA. In this paper, we describe the preparation of different inhouse antigens for detection of human coccidioidal IgG by ID and EIA that can be an alternative to commercial kits.
Materials and Methods
Fungal Strain A C. posadasii strain from the Specialized Medical Mycology Center's fungal collection (CEMM, Federal University of Ceará, Fortaleza, Brazil) was evaluated in this study. The strain (CEMM 01-06-092) was previously identified by mycological analysis and specific PCR, as described by Cordeiro et al. [23] and Umeyama et al. [16] , respectively. Strain manipulations were performed within a class II biological safety cabinet in a biosafety level 3 laboratory.
Culture Medium and Growth Conditions
The fungal culture was initially grown in potato dextrose agar for 10 days at 30°C. After this period, approximately 2 ml of sterile saline solution was added to the agar slant, and the culture was gently scraped with a cotton swab. The suspension was transferred to a 500-ml flask containing 100 ml of 2 % glucose and 1 % yeast extract broth (GYE) and incubated for 10 days at 30°C, being considered a pre-inoculum. After this period, the pre-inoculum was transferred to a 3-l flask containing 1,500 ml of GYE and further incubated as described above for 30 days.
Fungal Antigens
Antigen extraction was based in the protocol described by Brilhante et al. [21] , with modifications. The fungal culture was treated with 0.2 g l -1 of thimerosal (ethylmercurithiosalicylic acid sodium salt; Synth, Brazil), and the mixture was incubated at 30°C for 24 h or 30 days in order to obtain different exoantigens or cellular antigens, respectively. The supernatant was collected by paper filtration, and the proteins were salted out with the following concentrations of ammonium sulfate (Sigma, USA): 0-90, 0-30, 30-60 and 60-90 %. The mixtures were kept at 4°C for 24 h, and then the precipitated proteins were recovered by centrifugation (10,0009g, 30 min, 4°C) and dialyzed exhaustively against a 10X volume of distilled water in a dialysis membrane with a 10 kDa molecular mass cutoff. The samples were stored at -20°C until used for serological tests. Five different antigenic samples were obtained: exoantigen from 24-hour thimerosal treatment (Exo) and cellular antigens from 30-day thimerosal treatment (F0-30, F30-60, F60-90 and F0-90).
Antigen Characterization
The protein concentration of each antigenic extract was estimated by the Bradford assay [24] , using bovine serum albumin as standard. The electrophoretic profile of each extract was determined by SDS-PAGE, according to Laemmli [25] , with modifications. Samples were mixed with loading buffer (0.25 M Tris-HCl pH 8.0, 10 % SDS, 10 % b-mercaptoethanol, 20 % glycerol, 0.25 mg ml -1 bromophenol blue), heated at 100°C for 15 min and then centrifuged (13,0009g, 5 min). Volumes of 20 ll of the supernatant were electrophoresed in 12.5 % polyacrylamide gels under denaturation conditions. Gels were run at room temperature (18°C) for 5 h at 80 volts in buffer containing 25 mM Tris base, 200 mM, glycine and 0.1 % SDS pH 8.0. After electrophoresis, the gels were stained with Coomassie brilliant blue R250 (Sigma, USA). The molecular weights were determined through E-Capt software (version 12.7 for Windows), in comparison with standard protein markers (Bio-Rad Laboratories, USA).
The presence of charged carbohydrate was evaluated according to Rocha et al. [26] (2008). In brief, each antigenic extract was electrophoresed in a 6 % (wt/vol) polyacrylamide gel at room temperature for 4 h at 80 volts in diaminopropane acetate buffer (50 mM; pH 9.0). Gels were stained with 0.1 % (wt/ vol) toluidine blue solution. For comparison, high-and low-molecular-weight standards (Bio-Rad, USA) as well as standard chondroitin 4-sulfate and chondroitin 6-sulfate (Sigma, USA) were subjected to the same protocols, as indicated.
Serum Samples
A total of 26 serum samples from patients with acute pulmonary or disseminated CM were included in this study. All of them were diagnosed by culture and ID test with a commercial kit (IDCF antigen, Immy Immunomycologics, USA). Patients were negative for HIV and tuberculosis, by way of serologic and Mantoux test, respectively. Heterologous serum samples from patients with culture-based diagnosis for histoplasmosis (HM; n = 10) and paracoccidioidomycosis (PM; n = 7) were also included. In addition, serum samples from clinically healthy individuals without reactivity after commercial ID (n = 100) were included as negative controls. None of the healthy individuals have clinical evidence of tuberculosis or another respiratory disease. The investigation was approved by the ethics committee of Federal University of Ceará (Process number 35/04).
ID Assays
ID assays were performed as described by Camargo et al. [27] . Briefly, the tests were performed with 1 % agarose in PBS solution. Slides were prepared with a central well surrounded by six wells (diameter 3 mm), each one placed 6 mm away. Each well was filled with 20 ll of antigen preparation or serum sample, and the slides were incubated for 24 h in a moist chamber at 28°C. Serum samples from patients with CM, HM and PM were also tested after heating at 63°C for 13 min for IgM inactivation [28] . The slides were washed with 5 % sodium citrate for 1 h and then for 24 in PBS buffer. Then the slides were stained with 0.15 % Coomassie brilliant blue in ethanol/acetic acid/deionized water (4:2:4) and destained with the solvent mixture whenever necessary. Precipitin bands between antigen and antibody wells were then recorded.
EIAs
In brief, microtiter plates (Corning Costar, USA) were coated with 50 ll of each antigen preparation (1.0, 2.5 and 5.0 lg of protein per well) and incubated overnight at 4°C. After blockage with 1 % BSA (Calbiochem, USA) for 90 min at 37°C, the plates were washed four times with PBS-Tween 20 (0.05 %), and 50 ll of each serum sample (1:400-1:51200 dilution) was added to each well. The plates were incubated at 37°C for 1 h and then washed again three times with PBS-Tween. The plates were incubated with 100 ll peroxidase-labeled goat anti-human IgG (1:2000 dilution; Sigma, USA) for 1 h at 37°C. After four washes with PBS-Tween, the reaction was developed by adding 100 ll OPD (orthophenylenediamine) solution (0.4 mg ml The absorbance was measured on a microplate reader at 492 nm. The EIAs were performed using serum samples from patients with pulmonary or disseminated CM (n = 26) and heterologous serum samples from patients with HM (n = 10) and PM (n = 7). A total of 58 serum samples from healthy individuals were randomly chosen and included in each set of experiments.
Data Analysis
To calculate the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) for the experimental ID tests, the following formulas were used: Sensitivity was equal to A/(A ? C); specificity was equal to D/(B ? D); PPV was equal to A/(A ? B); and NPV was equal to D/ (C ? D), where A is a specimen with a positive result by both experimental ID and the traditional tests (culture and/or commercial ID test); B is a specimen with a positive result by experimental ID but negative results by the traditional tests; C is a specimen with a negative result by experimental ID but positive results by the traditional test; and D is a specimen with negative results by both types of assays (experimental ID and traditional tests).
Sensitivity, specificity and optimal cutoff values of indirect EIAs were determined for each antigen preparation by using receiver operating characteristic (ROC) curve analysis. The area under the ROC curve (AUC) was calculated and compared.
Results

Antigenic Extracts
Five antigenic extracts were obtained: Exo, F0-30, F30-60, F60-90 and F0-90. The Bradford assay revealed the following amounts of total proteins in the antigenic extracts: Exo, 21.57 lg ml -1 ; F30-60, 9.78 lg ml -1 ; F60-90, 303.0 lg ml -1 ; and F0-90, 567.0 lg ml -1
. The protein content of the F0-30 antigen was undetectable (\0.1 lg ml -1 ). The SDS-PAGE profile of each antigenic extract revealed proteins with different molecular weights (Fig. 1) . Preliminary analysis did not reveal the presence of charged carbohydrates in any of the antigenic extracts.
ID
By way of ID reactions, differences in reactivity of each antigenic extract were seen. Poor reactivity against sera of patients with CM (n = 26) was seen in Exo (n = 9, 34.61 %) and in F0-30 (n = 4, 15.38 %). The remaining antigenic preparations presented the following reactivity results: 11 (42.30 %), 15 (57.69 %) and 23 (88.46 %) for F30-60, F60-90 and F0-90, respectively. Similar pattern results were seen with both heated and unheated serum samples. None of the heterologous serum samples or the negative control samples (healthy individuals) presented positive reaction by ID. The data concerning sensitivity, specificity, positive predictive value and negative predictive value of each antigenic extract are shown in Table 1 .
EIA
Indirect EIAs were performed with only the following protein-rich extracts: Exo, F30-60, F60-90 and F0-90 (Fig. 2) . Reproducible results were obtained when the antigenic extracts were tested at 2.5 lg protein ml -1 . (Fig. 3) , the cutoff parameters were determined as follows: 0.8280, 1.497, 0.5895 and 0.3270 for Exo, F30-60, F60-90 and F0-90, respectively. The parameters regarding specificity, sensitivity, confidence intervals and AUC for each antigen are displayed in Table 2 .
Discussion
Coccidioides serology has a long and well-documented history. Pioneering studies developed by Cooke [29] with grinded cultures of C. immitis as antigenic extract, and the outstanding research conducted by Smith et al. [30, 31] with more than 39,000 serological tests have assisted to set up the currently serological protocols for the diagnosis and prognosis of CM.
In the recent years, several studies have highlighted the importance of serological tests for the diagnosis and follow-up of patients with CM [10, 20, [32] [33] [34] . Presumptive diagnosis of CM can be achieved by ID tests, which can detect IgM or IgG antibodies raised against ''tube precipitin'' or ''complement fixation'' antigens and thus provide information on the status of the disease [35, 36] . ID testing is very popular among routine laboratories because of its simplicity and reliability [37] . Despite these advantages, ID tests can present great variability regarding sensitivity [37] and cross-reactions with histoplasmosis (HM) sera may occur [36, 37] , even against purified antigens [38] .
In the present study, it was shown that all of the antigenic extracts tested by ID were able to recognize serum samples from patients with CM. However, the highest sensitivity and specificity values were obtained with antigen F0-90. ID performed against F0-90 also showed higher values of PPV and NPV, which indicates that the test with this antigen is most likely correct in its assessment. The absence of crossreactions suggests the potential of this test for presumptive diagnosis of CM. Despite the low protein content of the F0-30 antigen, positive reactions among CM serum samples were seen. We suppose that trace amounts of structural carbohydrates may have contributed to the observed reactivity. EIAs have been widely employed for CM diagnosis in endemic regions of the USA [10, 33, 35, [39] [40] [41] . However, differences regarding sensitivity, specificity and predictive values have been observed among EIAs. Martins et al. [40] showed that combined IgM and IgG EIA tests had specificity of 98.5 % and sensitivity of 94.8 %. By using complement fixation tests as reference, Zartarian et al. [41] presented a commercial EIA that had specificity of 98 % and sensitivity of 100 %. In Latin America, Tiraboschi et al. [42] evaluated the reactivity of an experimental EIA and found sensitivity of 72 % and specificity of 85 %. In our study, we observed that both F0-90 and F60-90 antigens were suitable for detection of coccidioidal IgG by indirect EIA. However, the F60-90 antigen showed the highest levels of sensitivity, specificity, PPV and NPV. The reactivity parameters obtained with F60-90 EIA were similar to those found in other studies [33, 35, 43, 44] .
EIAs for detection of coccidioidal antibody have shown a considerable degree of cross-reactions with sera from patients with blastomycosis or HM. In a seminal study performed by Yang et al. [38] , a recombinant protein with chitinase activity was found to express epitopes that reacted with sera from patients with blastomycosis or HM. In addition, cross-reactivity has been described in all available serological methods, including complement fixation, ID and EIA directed at antigen detection [39] , as well as in sera from patients with non-mycotic diseases tested by ID and complement fixation tests [36] .
In the present study, cross-reactions with HM and paracoccidioidomycosis (PM) serum samples were seen in the EIAs with all of the antigens. However, fewer cross-reactions occurred with F60-90 (PM = 1; HM = 1) and F0-90 (PM = 1) antigens. Although one may argue that cross-reactions can compromise the usefulness of our EIA, it is important to note that undesired false-positive reactions occur even with commercial kits for coccidioidal antibody detection [39, 45] . Cross-reactions against unrelated pathogens in a commercial EIA kit have also been described [46] . Besides that, patients with CM, PM and HM can present peculiar clinical characteristics. In addition, these mycoses occur in distinct endemic areas in South America [47] . Taken together, this information may help to interpret the F60-90 EIA results. Therefore, we believe that F60-90 EIA has potential to be used as a screening tool for CM diagnosis in routine laboratories in South America. One of the major drawbacks of tests with in-house antigens is that their quality can vary from batch to batch. Although this question has not been extensively investigated in our study, we have also prepared antigenic extracts from two other C. posadasii cultures (clinical strain CEMM 01-06-085 and environmental stain CEMM 01-06-101) and run the same tests regarding antigen characterization described in Materials and Methods section. Antigenic extracts showed similar reactivity by way of ID and EIA against a random set of sera samples (data not shown). Taken together, these data suggest that little variability is expected to happen with these antigens. Although C. posadasii is considered a dangerous pathogen, it is possible to apply standardized and safe techniques to guarantee the production of both antigens in a commercial scale.
In conclusion, the present study showed that the F0-90 and F60-90 antigens have a potential to be employed in presumptive diagnosis of CM by way of ID or indirect EIA, respectively. The tests are inexpensive, easy to perform and rely on reagents and equipment achievable to small laboratories in South America.
